ストックスクリーナーアプリを入手
346.23
0.58%
1.98
前日終値:
$344.25
開ける：
$343.87
24時間の取引高:
537.79K
Relative Volume:
0.80
時価総額：
$24.37B
収益：
$3.22B
当期純損益:
$542.70M
株価収益率:
46.28
EPS:
7.4805
ネットキャッシュフロー:
$458.00M
1週間 パフォーマンス:
+1.84%
1か月 パフォーマンス:
-1.46%
6か月 パフォーマンス:
+45.32%
1年 パフォーマンス:
+31.28%
1日の値動き範囲:
$341.68
$351.96
1週間の範囲:
$331.99
$351.96
52週間の値動き範囲:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
346.23 | 24.37B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
369.15 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
177.85 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.03 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.27 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.53 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - Investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com
West Pharmaceutical stock gains as UBS lifts price target to USD 415 - ad-hoc-news.de
Is West Pharmaceutical Services (WST) Stock A Bargain Or Fully Priced? - webull.com
West Pharmaceutical stock heads before the bell after a 0.8 percent drop - ad-hoc-news.de
West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media
West Pharmaceutical stock gains after strong Q2 figures - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - indexbox.io
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - ad-hoc-news.de
West Pharma Sets September Investor Conference Appearances - MyChesCo
West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - ad-hoc-news.de
West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS
West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS
West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc. (WST) Peer Comparison – Compare with Others - Value Research
16,794 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Cibc World Market Inc. - MarketBeat
West to Participate in Upcoming Investor Conferences - PR Newswire
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. (WPS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock holds firm after Q2 beat - Ad-hoc-news.de
NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,440 West Pharmaceutical Services, Inc. $WST - MarketBeat
2,043,823 Shares in West Pharmaceutical Services, Inc. $WST Bought by Bank of New York Mellon Corp - MarketBeat
West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative - Yahoo Finance
West Pharmaceutical stock holds firm as analysts lift targets - Ad-hoc-news.de
Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
0.43%
0.60%
大文字化:
|
ボリューム (24 時間):